trihexyphenidyl has been researched along with Tauopathies in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshiyama, Y | 1 |
| Kojima, A | 1 |
| Itoh, K | 1 |
| Uchiyama, T | 1 |
| Arai, K | 1 |
1 other study available for trihexyphenidyl and Tauopathies
| Article | Year |
|---|---|
Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
Topics: Animals; Benzilates; Cholinergic Antagonists; Disease Models, Animal; Hippocampus; Inflammation; Mic | 2012 |